<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Messina JA</submitter><funding>Parker Institute for Cancer Immunotherapy</funding><funding>MSK Cancer Center</funding><funding>National University of Singapore Development</funding><funding>NIA NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>National Heart, Lung, and Blood Institute</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>National Institute on Aging</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Enterococcus intestinal domination (EID), a state of dysbiosis wherein enterococci comprise ≥30% abundance within the microbiota, has been associated with Enterococcus bacteremia, graft-versus-host disease, and mortality in the allogeneic hematopoietic stem cell transplant (allo HCT) population. The acute leukemia (AL) chemotherapy population includes patients receiving intensive chemotherapy but do not all go on to have an allo HCT. The impact of EID on outcomes including mortality in the AL chemotherapy population is unknown.&lt;h4>Methods&lt;/h4>Microbiota composition from weekly stool samples was analyzed by 16S ribosomal RNA gene sequencing. Patients were analyzed in 2 cohorts: AL chemotherapy cohort and allo HCT cohort. Alpha-diversity and richness were calculated. Kapla</pubmed_abstract><journal>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</journal><pagination>ciab1043</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10874263</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Enterococcus Intestinal Domination is Associated with Increased Mortality in the Acute Leukemia Chemotherapy Population.</pubmed_title><pmcid>PMC10874263</pmcid><funding_grant_id>P01-CA023766</funding_grant_id><funding_grant_id>P01-AG052359</funding_grant_id><funding_grant_id>P30 CA008748</funding_grant_id><funding_grant_id>R01 HL123340</funding_grant_id><funding_grant_id>K08HL143189</funding_grant_id><funding_grant_id>K23 AI163365</funding_grant_id><funding_grant_id>R21 AG066388</funding_grant_id><funding_grant_id>R01 HL147584</funding_grant_id><funding_grant_id>R01-R01-HL147584</funding_grant_id><funding_grant_id>P01 AG052359</funding_grant_id><funding_grant_id>R21AG066388</funding_grant_id><funding_grant_id>T32 AI100851</funding_grant_id><funding_grant_id>R01-CA228308,</funding_grant_id><funding_grant_id>P01 CA023766</funding_grant_id><funding_grant_id>K08 HL143189</funding_grant_id><funding_grant_id>R01-CA228358</funding_grant_id><funding_grant_id>R01-HL123340</funding_grant_id><funding_grant_id>R01 CA228308</funding_grant_id><funding_grant_id>R01 CA228358</funding_grant_id><pubmed_authors>Messina JA</pubmed_authors><pubmed_authors>Sung AD</pubmed_authors><pubmed_authors>van den Brink MRM</pubmed_authors><pubmed_authors>Ren Y</pubmed_authors><pubmed_authors>Gomes A</pubmed_authors><pubmed_authors>Peled JU</pubmed_authors><pubmed_authors>Chao NJ</pubmed_authors><pubmed_authors>Bush A</pubmed_authors><pubmed_authors>Andermann T</pubmed_authors><pubmed_authors>Tan CY</pubmed_authors><pubmed_authors>Lew M</pubmed_authors><pubmed_authors>Surana NK</pubmed_authors><pubmed_authors>Hill L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Enterococcus Intestinal Domination is Associated with Increased Mortality in the Acute Leukemia Chemotherapy Population.</name><description>&lt;h4>Background&lt;/h4>Enterococcus intestinal domination (EID), a state of dysbiosis wherein enterococci comprise ≥30% abundance within the microbiota, has been associated with Enterococcus bacteremia, graft-versus-host disease, and mortality in the allogeneic hematopoietic stem cell transplant (allo HCT) population. The acute leukemia (AL) chemotherapy population includes patients receiving intensive chemotherapy but do not all go on to have an allo HCT. The impact of EID on outcomes including mortality in the AL chemotherapy population is unknown.&lt;h4>Methods&lt;/h4>Microbiota composition from weekly stool samples was analyzed by 16S ribosomal RNA gene sequencing. Patients were analyzed in 2 cohorts: AL chemotherapy cohort and allo HCT cohort. Alpha-diversity and richness were calculated. Kapla</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2026-06-12T03:09:13.659Z</modification><creation>2024-11-14T13:25:04.114Z</creation></dates><accession>S-EPMC10874263</accession><cross_references><pubmed>34928341</pubmed><doi>10.1093/cid/ciab1043</doi></cross_references></HashMap>